TITLE

Risk factors of thrombosis in abdominal veins

AUTHOR(S)
Dutta, Amit Kumar; Chacko, Ashok; George, Biju; Joseph, Joseph Anjilivelil; Nair, Sukesh Chandran; Mathews, Vikram; Dickey, William; Koutroubakis, Ioannis E.; Gassler, Nikolaus
PUB. DATE
July 2008
SOURCE
World Journal of Gastroenterology;7/28/2008, Vol. 14 Issue 28, p4518
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
AIM: To estimate the prevalence of inherited and acquired thrombophilic risk factors in patients with abdominal venous thrombosis and to compare the risk factor profiles between Budd-Chiari syndromes (BCS) and splanchnic vein thrombosis (SVT). METHODS: In this retrospective study, 36 patients with abdominal venous thrombosis were studied. The patients were divided into Budd-Chiari group (hepatic vein, IVC thrombosis) and splanchnic venous thrombosis group (portal, splenic, superior mesenteric veins) based on the veins involved. Hereditary and acquired thrombophilic risk factors were evaluated in all patients. RESULTS: Twenty patients had SVT, 14 had BCS, and 2 had mixed venous thrombosis. Ten patients (28%) had hereditary and 10 patients (28%) acquired thrombophilic risk factors. The acquired risk factors were significantly more common in the SVT group (SVT vs BCS: 45% vs 7%, χ² = 5.7, P = 0.02) while hereditary risk factors did not show significant differences between the two groups (SVT vs BCS: 25% vs 36%, χ² = 0.46, P = 0.7). Multiple risk factors were present in one (7%) patient with BCS and in 3 patients (15%) with SVT. No risk factors were identified in 57% of patients with BCS and in 45% of patients with SVT. CONCLUSION: Hereditary and acquired risk factors play an important role in the etiopathogenesis of abdominal venous thrombosis. Acquired risk factors are significantly more common in SVT patients while hereditary factors are similar in both groups.
ACCESSION #
35751490

 

Related Articles

  • Review: The Wells clinical prediction guide and D-dimer testing predict deep venous thrombosis: COMMENTARY. Perrier, Arnaud // ACP Journal Club;Jul/Aug2006, Vol. 145 Issue 1, p24 

    The article presents the author's views on the role of clinical assessment to predict the occurrence of deep venous thrombosis (DVT) in patients. Several studies have reported about the consistent prevalence of DVT in the low- and moderate-probability categories. The author revealed that highly...

  • Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis. Srkalovic, Gordan; Cameron, Marte G.; Deitcher, Steven R.; Kattke-Marchant, Kandice; Hussein, Mohamad A. // International Seminars in Surgical Oncology;2005, Vol. 2, p17 

    Background: Coagulation problems in amyloidosis are historically associated with bleeding tendencies (mostly Factor X abnormalities). Increased clotting was observed in isolated cases diagnosed with low-grade disseminated intravascular coagulation (DIC). Problem of venous thromboembolic disaease...

  • Aseptic cerebral venous thrombosis associated with abdominal tuberculosis. Kakkar, N.; Banerjee, A.K.; Vasishta, R.K.; Marwaha, N.; Deodhar, S.D. // Neurology India;Mar2003, Vol. 51 Issue 1, p128 

    Presents a letter to the editor about aseptic cerebral venous thrombosis associated with abdominal tuberculosis. Cases of a 35-year-old woman with a history of two-month diarrhea; Case of a 36-year-old woman with fever, abdominal pain and intestinal obstruction; Performance of necropsy; Area of...

  • Cerebral Vein Thrombosis: Screening of Acquired and Hereditary Thrombophilic Risk Factors. Sarraf, Payam; Ghaffarpoor, Majid; Poormahmoodian, Hosein; Harrirchian, Hosein; Hashemi, Hasan // Acta Medica Iranica;2009, Vol. 47 Issue 3, p197 

    Cerebral vein thrombosis (CVT) is an infrequent condition with a large variety of causes that can lead to serious disabilities. However, in 20% to 35% of cases, no cause is found. In this study we evaluated the hereditary (P & C Proteins, antithrombin, mutation of prothrombin G20210A and factor...

  • DEEP VEIN THROMBOSIS: INCIDENCE, FACTORS PREDISPOSING, KINETOTERAPY. Zamora, Elena; Gligor, Elena; Gligor, Daniel; Konya, I. // Studia Universitatis Babes-Bolyai, Educatio Artis Gymnasticae;2009, Vol. 54 Issue 4, p13 

    DVT is a relatively common disease, potentially fatal, in the awareness of subjects and kinetoprofilaxie measures (exercise legs every 2 to 3 hours to get the blood flowing back to the heart) are of great importance. The number of patients with DVT interned in the department of cardiology...

  • ACTIVATED PROTEIN C RESISTANCE ASSOCIATED WITH THE COMMON CAROTID ARTERY THROMBOSIS IN THE CASE OF A YOUNG PATIENT. Mutu, C.; Pereanu, M. // Acta Medica Transilvanica;dec2011, Vol. 2 Issue 4, p193 

    The activated protein C resistance (factor V Leiden deficiency) represents the most common risk factor for thromboses which is inherited. Underdiagnosed as prevalence and reported in the cases of venous thrombotic pathology can be also associated with arterial thrombosis. We present the case of...

  • Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution. Cervantes, F.; Alvarez-Larrán, A.; Arellano-Rodrigo, E.; Granell, M.; Domingo, A.; Montserrat, E. // Leukemia (08876924);Jan2006, Vol. 20 Issue 1, p55 

    Thrombosis is a frequent complication of polycythemia vera and essential thrombocythemia, but its incidence and predisposing factors in idiopathic myelofibrosis (IM) are unknown. In 18 (11.6%) of 155 patients diagnosed with IM in a single institution, 31 thrombotic events (19 arterial, 12...

  • Evaluation of Suspected Deep Venous Thrombosis in Oncologic Patients. Keefe, Deborah L.; Roistacher, Nancy; Pierri, Mary Kathryn // Angiology;Sep1994, Vol. 45 Issue 9, p771 

    Impedance plethysmography (IPG) and duplex scanning with color flow Doppler were performed in 100 consecutive high-risk patients with clinically suspected deep venous thrombosis. Risk factors included recent surgery (

  • CV risks of oral HT vary according to estrogen type.  // Endocrine Today;Dec2013, Vol. 11 Issue 12, p40 

    The article reports that according to a new study, published in the periodical "JAMA Internal Medicine," use of oral conjugated equine estrogens may increase the risk for venous thrombosis and myocardial infarction, in comparison to the use of oral estradiol.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics